Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Revenue

Marker Therapeutics had revenue of $861.18K in the quarter ending June 30, 2025, a decrease of -26.35%. This brings the company's revenue in the last twelve months to $5.39M, up 44.55% year-over-year. In the year 2024, Marker Therapeutics had annual revenue of $6.59M with 99.06% growth.

• Revenue (ttm): $5.39M
• Revenue Growth: +44.55%
• P/S Ratio: 1.80
• Revenue / Employee: $1,077,614
• Employees: 5
• Market Cap: 11.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.59M	3.28M	99.06%
Dec 31, 2023	3.31M	-202.41K	-5.76%
Dec 31, 2022	3.51M	2.27M	182.96%
Dec 31, 2021	1.24M	774.93K	166.01%
Dec 31, 2020	466.79K	253.59K	118.95%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.